Biodegradable osmotic pump implant for drug delivery
View Patent ↗The present disclosure relates to a drug delivery device including a biodegradable housing and a hydrogel within the biodegradable housing. The housing, the hydrogel, or both, may include a bioactive agent. Also disclosed is a method of drug delivery including the steps of forming the biodegradable housing, in embodiments a hydrogel, suspending a bioactive agent in the hydrogel, and introducing a second hydrogel and/or precursors of a second hydrogel into the biodegradable housing.
1. An implantable drug delivery device comprising:
a biodegradable pouch comprising a biodegradable polymeric material comprising a first precursor comprising electrophilic groups and a second precursor comprising nucleophilic groups; and
a biodegradable hydrogel formed of a first hydrogel precursor comprising electrophilic groups and a second hydrogel precursor comprising nucleophilic groups within said biodegradable pouch;
wherein the biodegradable polymeric material, the biodegradable hydrogel, or both, comprises a bioactive agent.
2. The implantable drug delivery device of claim 1 , wherein the electrophilic groups of the first hydrogel precursor comprise N-hydroxysuccinimides and the nucleophilic groups of the second hydrogel precursor comprise amines.
3. The implantable drug delivery device of claim 1 , wherein the biodegradable polymeric material comprises a second hydrogel capable of a changing in size by a weight decrease of from about 1% to about 50% or a weight increase from about 0% to about 50%, and the biodegradable hydrogel swells by an amount of from about 40% by weight to about 600% by weight.
4. The implantable drug delivery device of claim 1 , wherein the first precursor comprises a multi-armed precursor possessing a core and arms, the arms each comprising a polyethylene glycol having a molecular weight from about 250 to about 5000.
5. The drug delivery device of claim 4 , wherein the core is selected from the group consisting of polyethers, polyamino acids, proteins, and polysaccharides.
6. The implantable drug delivery device of claim 4 , wherein the core is selected from the group consisting of polyethylene glycol, polyethylene oxide, polyethylene oxide-co-polypropylene oxide, co-polyethylene oxide copolymers, polyvinyl alcohol, polyvinyl pyrrolidinone, dextran, chitosan, carboxymethylcellulose, oxidized cellulose, derivatives thereof, and combinations thereof.
7. The implantable drug delivery device of claim 1 , wherein the nucleophilic groups comprise amines.
8. The implantable drug delivery device of claim 1 , wherein the biodegradable polymeric material comprises a low-swelling hydrogel capable of a changing in size by a weight decrease of from about 5% to about 30% or a weight increase from about 10% to about 40%, and the biodegradable hydrogel swells by an amount of from about 100% by weight to about 400% by weight.
9. The implantable drug delivery of claim 1 , wherein the biodegradable polymeric material is selected from the group consisting of oxidized cellulose, polylactide, polyglycolide, polylactide-co-glycolide copolymer, and combinations thereof.
10. The implantable drug delivery device of claim 1 , wherein the biodegradable pouch further comprises an inner layer and at least one outer layer.
11. The implantable drug delivery device of claim 10 , wherein the at least one outer layer is selected from the group consisting of oxidized cellulose, polylactide, polyglycolide, polylactide-co-glycolide copolymer, and combinations thereof.
12. The implantable drug delivery device of claim 10 , wherein the at least one outer layer comprises a molecular weight cut off membrane.
13. The implantable drug delivery device of claim 1 , wherein the bioactive agent is selected from the group consisting of local anesthetics, vitamins, hormones, and combinations thereof.
14. The implantable drug delivery device of claim 1 , wherein the biodegradable pouch is semi-permeable.
15. The implantable drug delivery device of claim 1 , wherein the bioactive agent is encapsulated in a polymeric microcapsule.
16. The implantable drug delivery device of claim 1 , wherein the implantable drug delivery device possesses a shape selected from the group consisting of circular, discs, rods, cylinders, capsules, spheres, ovoids, pinwheels, nautilus, and combinations thereof.
17. A method of drug delivery comprising the steps of:
forming a housing comprising a polymeric material in situ, the polymeric material comprising a first precursor comprising electrophilic groups and a second precursor comprising nucleophilic groups;
introducing at least one bioactive agent and precursors comprising a biodegradable hydrogel into the housing, the precursors comprising a first hydrogel precursor comprising electrophilic groups and a second hydrogel precursor comprising nucleophilic groups; and
allowing the precursors to form the biodegradable hydrogel within the housing.
18. The method of claim 17 , further comprising the step of hydrating the biodegradable hydrogel prior to filling the housing.
19. The method of claim 17 , further comprising dehydrating the biodegradable hydrogel prior to filling the housing.
20. The method of claim 17 , further comprising coating the housing with at least one outer layer.
21. The method of claim 17 , wherein the housing is coated with from about 1 to about 10 outer layers.